LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.07
EUR
0.08
EUR
4.18 %
30.04.2026
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 2.32 USD | -0.09 USD | -3.55 % |
|---|
| Vortag | 2.41 USD | Datum | 29.04.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Morpho ETP | CH1506167027 | 66.77% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 34.44% | |
| 21Shares Bittensor ETP | CH1495416971 | 15.40% | |
| 21Shares Render ETP | CH1396343266 | 0.92% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -0.79% | |
| 21Shares Algorand ETP | CH1146882316 | -1.11% | |
| 21Shares Dogecoin ETP | CH1431521033 | -8.70% | |
| 21Shares Jupiter ETP | CH1480821383 | -12.34% | |
| 21Shares Injective Staking ETP | CH1360612134 | -14.31% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -17.52% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | 0.99% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | -14.77% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | -18.73% | |
| 21Shares Artificial Superintelligence Alliance ETP | CH1480821375 | -19.09% | |
| 21Shares Render ETP | CH1396343266 | -24.64% | |
| 21Shares Bittensor ETP | CH1495416971 | -40.48% | |
| 21Shares Dogecoin ETP | CH1431521033 | -41.81% | |
| 21Shares Maple Finance ETP | CH1495416989 | -42.98% | |
| 21Shares XDC Network ETP | CH1464217285 | -48.96% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -52.36% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Ethereum Core Staking ETP Acc | CH1209763130 | 29.59% | |
| 21Shares Ethereum Staking ETP | CH0454664027 | 28.52% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 20.18% | |
| 21Shares Bitcoin Cash ETP | CH0475552201 | 18.88% | |
| 21Shares Binance BNB ETP | CH0496454155 | 0.39% | |
| 21Shares Dogecoin ETP | CH1431521033 | -38.85% | |
| 21Shares Injective Staking ETP | CH1360612134 | -64.31% | |
| 21Shares Immutable ETP | CH1360612142 | -71.21% | |
| 21Shares Sui Staking ETP | CH1360612159 | -73.58% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 160.67% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 77.16% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 45.93% | |
| 21Shares Stellar ETP | CH1109575535 | 41.81% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 24.27% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 570’617.98 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 01.05.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 27.62 | |
| Performance 2 Jahre | 18.58 | |
| Performance 3 Jahre | -2.60 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
ETP Kategorievergleich
| Name | 1J Perf. | |
|---|---|---|
| ERSTE STOCK BIOTEC EUR D01 A Fonds | 28.58 | |
| ERSTE STOCK BIOTEC EUR R01 T Fonds | 28.59 | |
| ERSTE STOCK BIOTEC EUR R01 A Fonds | 28.59 | |
| ERSTE STOCK BIOTEC EUR D01 T Fonds | 28.59 | |
| ERSTE STOCK BIOTEC EUR VT Fonds | 28.59 |